The first to commercialize lactotripeptides

AmealPeptide^®, the first commercialized lactotripeptide, was developed by Calpis Co., Ltd. Since 1917, Calpis Co., Ltd., based in Tokyo, Japan, has manufactured and marketed fermented and cultured milk-based products. Perfecting the innovative microbiological technology used to produce AmealPeptide^® has kept the company at the forefront of global scientific achievement in lactic-acid fermentation processing.

Well-known and highly respected in Asia for years, Calpis' AmealPeptide^®-based products have been steadily gaining market share since their launch in the US, where they are increasingly recommended by physicians.

To learn more about AmealPeptide^® and how to use it to enhance your products, contact:

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

To learn more about Calpis, go to http://calpis.net/